How Much Weight Can You Lose on GLP-1 Medications?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed how doctors approach weight management, with clinical trials showing average weight loss of 10–22% of starting body weight depending on the medication and dosage. Your actual results depend on your metabolism, genetics, diet choices, and how consistently you use the medication. Understanding what realistic weight loss looks like helps you set achievable goals and track your progress.

Average Weight Loss With GLP-1 Medications

Semaglutide, one of the most studied GLP-1 medications, helped patients in clinical trials lose an average of 15% of their starting weight over 68 weeks of treatment. In the STEP trials, participants taking semaglutide lost significantly more weight than those on placebo, with weight loss continuing for the full duration of treatment. The medication works by reducing hunger signals in your brain and slowing how fast your stomach empties, making you feel fuller longer.

Individual results vary widely—some patients lose 5–10% of their weight while others achieve 20% or more. Factors like your starting weight, age, metabolism, physical activity level, and diet quality all influence your personal weight loss trajectory. PlexusDx works with licensed 503A compounding pharmacies to provide semaglutide injections that are $189/mo month-to-month, or from $149/mo on the 6-month plan, making this proven therapy accessible without insurance requirements.

Timeline: When You'll Notice Weight Loss Changes

Most patients begin noticing appetite suppression within the first 1–2 weeks of starting GLP-1 therapy, though visible weight loss typically appears around weeks 3–6. The first month often brings 1–3 pounds of weight loss as your body adjusts to reduced calorie intake from decreased hunger. Momentum builds over the following months, with average weight loss of 1–2 pounds per week becoming common by month two and beyond.

By month three, many patients see measurable changes in how their clothes fit and energy levels improve. The pace of weight loss typically plateaus around months 4–6, then continues at a slower but steady rate through months 6–12. This natural progression means patience is essential—rapid initial losses often slow, which is normal and healthy biology, not a sign of treatment failure.

Comparing Semaglutide, Tirzepatide, and Dual-Compound Options

Semaglutide targets GLP-1 receptors alone and produced average weight loss of 15% in landmark trials, making it highly effective for most patients. Tirzepatide activates both GLP-1 and GIP receptors, delivering average weight loss of 20–22% in clinical studies—roughly 5–7 percentage points greater than semaglutide. PlexusDx offers both medications as compounded injections, with tirzepatide at $289/mo month-to-month, or from $249/mo on the 6-month plan, giving you options based on your goals and medical history.

For patients seeking maximum effect, PlexusDx's GLP-Squared Injection combines semaglutide and tirzepatide in one dose, at $289/mo month-to-month, or from $249/mo on the 6-month plan. This dual-compound approach may appeal to those who didn't achieve desired results with a single medication or prefer optimized therapy from the start. Your healthcare provider at PlexusDx can help determine which option aligns with your weight loss targets and medical background.

Genetic Factors That Influence Your Weight Loss Potential

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The FTO gene variant, for example, influences how your body regulates hunger hormones and energy storage. Patients with certain genetic patterns may experience faster appetite suppression or more consistent weight loss with GLP-1 medications. PlexusDx maps 14 metabolic pathways across 49 peptides using 150+ genetic insights, allowing your provider to optimize your medication choice and dosing strategy for maximum personal benefit.

How to Maximize Your Weight Loss Results

Medication is a tool, not a substitute for healthy habits—combining GLP-1 therapy with consistent exercise, whole-food nutrition, and adequate sleep produces the best outcomes. Patients who lose the most weight typically walk 150+ minutes per week, prioritize protein intake, and drink sufficient water to support metabolism and reduce false hunger signals. GLP-1 medications make these healthy choices easier by reducing cravings and food noise, but your daily decisions still matter enormously.

Track your progress beyond the scale by monitoring energy levels, clothes fit, blood sugar stability, and how you feel during physical activity. Weight loss isn't always linear—many patients experience 2–3 week plateaus followed by sudden drops, which is completely normal. PlexusDx supports your journey with licensed 503A compounded medications at $189/mo month-to-month, or from $149/mo on the 6-month plan for semaglutide, HSA/FSA eligibility, and access to healthcare guidance—no membership fees or insurance requirements needed.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I personally lose with GLP-1?

Average weight loss ranges from 10–22% of starting body weight depending on the specific medication, your genetics, lifestyle, and how long you use it. PlexusDx's Precision Peptide Genetic Test can reveal your individual genetic predispositions for GLP-1 response, helping your provider set more accurate expectations for your situation.

What clinical evidence supports GLP-1 weight loss claims?

The STEP clinical trials demonstrated that semaglutide produced average weight loss of 15% over 68 weeks, while tirzepatide achieved 20–22% in similar studies. These results represent sustained weight loss in real patients taking the medication as prescribed, not temporary or short-term changes.

Is PlexusDx semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A pharmacies using FDA-approved reference formulations and rigorous quality standards. While PlexusDx does not manufacture FDA-approved products, the active ingredient and compounding process meet strict regulatory requirements for safety and efficacy.

Will I regain weight if I stop taking GLP-1?

Some weight regain is common after stopping GLP-1 therapy because appetite hormones return to baseline, but research shows most patients maintain 50–70% of their weight loss long-term if they sustain healthy habits.

How can genetic testing help me achieve better results?

No — the Precision Peptide Genetic Test does not predict your response to GLP-1 medications or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp 1 For Losing Weight
• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.